Abstract
As compared to normolipoproteinemic controls 10 male subjects with primary type IV hyperlipoproteinemia had higher apolipoprotein E and lower apolipoprotein C-II concentrations in the very low density lipoprotein (VLDL) fraction. After 8 weeks of treatment with 0.6. g/day bezafibrate, cholesterol and triglyceride in the serum and VLDL were significantly lower. The decrease of VLDL lipids was accompanied by a significant decrease of the apolipoproteins and of the lipid/protein ratio in VLDL. The analysis of the soluble VLDL apolipoproteins revealed a decrease of apo E and an increase of apo C1 and apo C2, resulting in a decrease of the apo E/apo C ratio.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
